Intrinsic Value of S&P & Nasdaq Contact Us

Longeveron Inc. LGVN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+792.9%

Longeveron Inc. (LGVN) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 4 Buy.

The consensus price target is $10.00, representing an upside of 792.9% from the current price $1.12.

Analysts estimate Earnings Per Share (EPS) of $-3.69 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.07 vs est $-3.69 (beat +71%). 2025: actual $-1.29 vs est $-1.43 (beat +9.6%). Analyst accuracy: 0%.

LGVN Stock — 12-Month Price Forecast

$10.00
▲ +792.86% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Longeveron Inc., the price target is $10.00.
The average price target represents a +792.86% change from the last price of $1.12.

LGVN Analyst Ratings

Buy
4
Ratings
4 Buy
Based on 4 analysts giving stock ratings to Longeveron Inc. in the past 3 months
Rating breakdown
Buy
4 100%
100%
Buy
4 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — LGVN

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.07 vs Est –$3.69 ▲ 244.5% off
2025 Actual –$1.29 vs Est –$1.43 ▲ 10.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — LGVN

83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.002B vs Est $0.002B ▲ 9.8% off
2025 Actual $0.001B vs Est $0.001B ▲ 23.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message